Table 1
BRAF mutation and clinicopathologic factors

Variable	Patients with BRAF mutation (%)	P value
Gender (n=22)
Male (n=14)	4 (28.6)	0.190
Female (n=8)	2 (25.0)
Age (yr) (n=22)
≤60 (n=13)	4 (30.8)	0.210
>60 (n=9)	2 (22.2)
Breslow thickness (mm) of primary cutaneous melanoma (n=10)
<2 (n=4)	1 (25.0)	0.301
2–5 (n=4)	1 (20.0)
>5 (n=2)	1 (50.0)
Ulceration of primary cutaneous melanoma (n=10)
Present (n=5)	2 (40.0)	0.172
Absent (n=5)	1 (20.0)
Site of metastatic melanoma (n=18)
Lymph node (n=14)	4 (28.6)	<0.001
Others (n=4)	0